LEN
32
-4
ROST
68
-4
PFE
46
-4
BF.B
54
-4
O
48
-2
RSG
45
-2
VNO
49
3
NRG
55
3
LYB
13
2
CB
65
4
BSX
52
-2
ACN
54
2
BBY
40
2
WU
41
2
MLM
60
-6
NDAQ
69
2
IFF
54
-2
DVN
44
-3
ORLY
44
-4
VZ
34
-8
LEN
32
-4
ROST
68
-4
PFE
46
-4
BF.B
54
-4
O
48
-2
RSG
45
-2
VNO
49
3
NRG
55
3
LYB
13
2
CB
65
4
BSX
52
-2
ACN
54
2
BBY
40
2
WU
41
2
MLM
60
-6
NDAQ
69
2
IFF
54
-2
DVN
44
-3
ORLY
44
-4
VZ
34
-8
Financhill
Back

Q2 Holdings, Inc. Vs. Kymera Therapeutics, Inc. Industry Stock Comparison

Buy
70

QTWO
Q2 Holdings, Inc.

Last Price:
$74.54
Seasonality Move:
3.68%
Buy
87

KYMR
Kymera Therapeutics, Inc.

Last Price:
$89.98
Seasonality Move:
7.7%
Buy
70
Q2 Holdings, Inc. (QTWO) is a Buy

Is Q2 Holdings, Inc. a Buy, Sell or Hold?

  • The current Q2 Holdings, Inc. [QTWO] share price is $73.90. The Score for QTWO is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
  • QTWO is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
87
Kymera Therapeutics, Inc. (KYMR) is a Buy

Is Kymera Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Kymera Therapeutics, Inc. [KYMR] share price is $86.88. The Score for KYMR is 87, which is 74% above its historic median score of 50, and infers lower risk than normal.
  • KYMR is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.

QTWO Stock Price Chart

What is Q2 Holdings, Inc.'s stock price today?

  • The Q2 Holdings, Inc. share price today is $73.90
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and QTWO is experiencing slight buying pressure.

KYMR Stock Price Chart

What is Kymera Therapeutics, Inc.'s stock price today?

  • The Kymera Therapeutics, Inc. share price today is $86.88
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing slight selling pressure.

QTWO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.55 Buy
Relative Strength Index (14 RSI): 61.55 Buy
Chaikin Money Flow: 131006 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (67.79 - 74.35) Buy
Bollinger Bands (100): (65.21 - 81.67) Buy

KYMR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.97 Buy
Relative Strength Index (14 RSI): 72.81 Buy
Chaikin Money Flow: -897315 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (58.72 - 73.96) Buy
Bollinger Bands (100): (43.27 - 64.19) Buy

QTWO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 72.77 Buy
20-day SMA: 71.98 Buy
50-day SMA: 67.08 Buy
200-day SMA: 78.83 Sell
8-day EMA: 72.9 Buy
20-day EMA: 71.4 Buy
50-day EMA: 70.64 Buy
200-day EMA: 76.6 Sell

KYMR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 72.38 Buy
20-day SMA: 67.89 Buy
50-day SMA: 62.54 Buy
200-day SMA: 44.51 Buy
8-day EMA: 75.59 Buy
20-day EMA: 69.41 Buy
50-day EMA: 62.91 Buy
200-day EMA: 49.79 Buy

Q2 Holdings, Inc. Earnings Growth & QTWO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.76 per share, and an increase next year of $0.41 per share.

Kymera Therapeutics, Inc. Earnings Growth & KYMR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.63 per share, and a decrease next year of $0.36 per share.

Q2 Holdings, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Kymera Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):